Page last updated: 2024-08-24

gemcitabine and pseudolaric acid b

gemcitabine has been researched along with pseudolaric acid b in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, X; Niu, Q; Song, W; Tian, Z; Wu, J; Xie, M; Xu, Y; Yang, L; Zhang, C; Zhang, Q; Zhao, X; Zhou, B	1

Other Studies

1 other study(ies) available for gemcitabine and pseudolaric acid b

Article	Year
Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell. Yonsei medical journal, 2018, Volume: 59, Issue:1 Topics: Animals; Antigens, CD; Antineoplastic Agents; Biomarkers, Tumor; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Deoxycytidine; Diterpenes; Epithelial-Mesenchymal Transition; Female; Fibronectins; Gemcitabine; Humans; Mice, Nude; Neoplasm Invasiveness; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Signal Transduction; Vimentin	2018

Article

Year

Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell.

Yonsei medical journal, 2018, Volume: 59, Issue:1

Topics: Animals; Antigens, CD; Antineoplastic Agents; Biomarkers, Tumor; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Deoxycytidine; Diterpenes; Epithelial-Mesenchymal Transition; Female; Fibronectins; Gemcitabine; Humans; Mice, Nude; Neoplasm Invasiveness; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Signal Transduction; Vimentin

2018